Tests electromagnetic stimulation chair for fecal incontinence after pouch surgery
Tests a focused electromagnetic chair in adults with ulcerative colitis and fecal incontinence.
Plain-language title generated from the registry record
Registry title: Functional Outcomes in Ulcerative Colitis Patients With Ileal Pouch Anal Anastomosis Treated With High Intensity Focused Electromagnetic Stimulation
Key facts
- Where
- Los Angeles, United StatesSee the site
Where in United States
- Cedars-Sinai Medical CenterLos Angeles, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Cedars-Sinai Medical Center
- Trial code
- NCT07034443
- Record updated
- 12 August 2026
- Original description
The purpose of this research is to evaluate functional outcomes in patients with Ulcerative Colitis and IBDU who have received an ileal pouch anal anastomosis (IPAA), commonly referred to as a J pouch, after treatment with the Emsella chair. We will specifically look at fecal incontinence and patient health related quality of life outcomes before, during and after course of treatment.Read full original descriptionShow less
Functional Outcomes in Ulcerative Colitis Patients With Ileal Pouch Anal Anastomosis Treated With High Intensity Focused Electromagnetic Stimulation: A Prospective Pilot Study
The purpose of this research is to evaluate functional outcomes in patients with Ulcerative Colitis and IBDU who have received an ileal pouch anal anastomosis (IPAA), commonly referred to as a J pouch, after treatment with the Emsella chair. We will specifically look at fecal incontinence and patient health related quality of life outcomes before, during and after course of treatment.
Inclusion: Individuals 18 years old or older are included; Patients who have a J pouch reconstruction due to Ulcerative Colitis or IBDU; Must be at least 1 year out from J pouch surgery; Have fecal incontinence.
Exclusion: Patients who received a J pouch for any other indication, including but not limited to Crohn's disease, familial adenosis polyposis; If reclassified to de novo Crohn's after surgery; Have an active fistula; Pediatric Patients <18 years of age; Any records flagged "break the glass" or "research opt out."; Did not receive a J pouch; Have active pouchitis; Have implanted metal devices or medical devices; Pregnant patients.